Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Blood Advances
|
May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
Rahul S Bhansali, Fredrik Ellin, Thomas Relander, et al.
Blood Advances
|
October 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Jessy Xinyi Han, Min Jung Koh, Leora Boussi, et al.
British Journal of Haematology
|
May 1, 2025
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study
Mark N Sorial, Jessy Xinyi Han, Min Jung Koh, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma
Pallawi Torka, Tatyana Feldman, Kerry J Savage, et al.
Blood Advances
|
May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
Rahul S Bhansali, Fredrik Ellin, Thomas Relander, et al.
Blood Advances
|
October 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Jessy Xinyi Han, Min Jung Koh, Leora Boussi, et al.
British Journal of Haematology
|
May 1, 2025
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study
Mark N Sorial, Jessy Xinyi Han, Min Jung Koh, et al.
Page
of 3